av/transmedics--big.svg

COM:TRANSMEDICS

Transmedics

  • Stock

Last Close

79.34

22/11 21:00

Market Cap

2.55B

Beta: -

Volume Today

2.60M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
8.62M
-
10.25M
18.81%
11.57M
12.97%
13.40M
15.74%
17.73M
32.36%
32.42M
82.83%
average payables
4.12M
-
5.98M
45.32%
4.23M
29.36%
3.93M
7.05%
5.00M
27.17%
8.03M
60.71%
average receivables
2.18M
-
5.00M
129.13%
6.71M
34.27%
6.40M
4.66%
16.77M
162.11%
45.59M
171.83%
book value per share
-11.65
-
-0.25
97.85%
3.85
1,634.59%
4.21
9.32%
2.46
41.58%
6.34
158.02%
0.00
99.93%
capex per share
-0.10
-
-0.02
82.21%
-0.02
19.56%
-0.01
46.52%
-0.02
58.57%
-0.13
591.80%
-0.40
216.16%
-0.00
98.84%
capex to depreciation
-3.47
-
-0.42
87.97%
-0.54
30.21%
-0.14
75.16%
-0.29
113.68%
-1.94
571.25%
-3.42
76.77%
-18.57
442.42%
capex to operating cash flow
0.06
-
0.01
81.43%
0.02
41.28%
0.01
68.23%
0.02
194.17%
0.12
710.95%
0.26
113.16%
11.66
4,384.90%
capex to revenue
-0.24
-
-0.03
85.62%
-0.03
6.17%
-0.01
78.23%
-0.02
153.87%
-0.12
555.26%
-0.13
9.56%
-0.63
393.27%
cash per share
1.70
-
1.05
38.26%
5.68
440.11%
5.09
10.46%
3.35
34.18%
6.81
103.33%
0.01
99.82%
days of inventory on hand
524.41
-
464.93
11.34%
420.27
9.61%
483.77
15.11%
595.80
23.16%
266.82
55.22%
184.46
30.87%
days payables outstanding
231.25
-
236.55
2.29%
271.55
14.80%
48.89
82.00%
266.68
445.49%
43.26
83.78%
53.03
22.57%
days sales outstanding
43.93
-
96.40
119.43%
101.42
5.21%
97.72
3.66%
71.57
26.76%
107.83
50.66%
96.04
10.94%
debt to assets
0.23
-
0.80
241.56%
0.32
59.40%
0.23
29.70%
0.06
72.02%
0.24
282.15%
0.65
165.47%
debt to equity
-0.05
-
-6.98
13,508.37%
0.62
108.95%
0.33
46.61%
0.13
61.99%
0.36
184.33%
3.33
823.63%
dividend yield
0.00
-
earnings yield
-0.07
-
-0.06
13.47%
-0.06
14.18%
-0.13
130.13%
-0.06
53.97%
-0.08
42.89%
-0.02
76.23%
-0.00
99.95%
enterprise value
320.45M
-
443.77M
38.49%
278.12M
37.33%
501.66M
80.38%
512.16M
2.09%
1.69B
230.09%
2.57T
151,718.62%
enterprise value over ebitda
-16.65
-
-22.55
35.44%
-9.65
57.19%
-20.28
110.15%
-12.71
37.36%
-52.12
310.13%
-89.35K
171,336.07%
ev to operating cash flow
-13.87
-
-17.08
23.10%
-8.61
49.56%
-16.58
92.42%
-17.74
7.05%
-36.90
107.95%
-197.01K
533,817.22%
ev to sales
41.70
-
34.09
18.24%
11.78
65.44%
19.57
66.06%
16.92
13.50%
18.09
6.88%
10.62K
58,622.95%
free cash flow per share
-1.77
-
-1.61
8.70%
-1.37
14.98%
-2.28
66.53%
-1.24
45.56%
-1.17
5.71%
-1.95
66.56%
-0.01
99.74%
free cash flow yield
-0.08
-
-0.07
8.70%
-0.06
14.98%
-0.12
100.30%
-0.06
49.15%
-0.06
2.07%
-0.03
48.30%
-0.00
99.80%
graham net net
-12.18
-
-1.01
91.67%
2.86
381.51%
3.59
25.63%
1.35
62.36%
4.82
256.83%
-0.00
100.07%
graham number
19.42
-
2.64
86.41%
14.30
441.86%
10.49
26.61%
9.41
10.35%
13.22
40.55%
0.01
99.94%
income quality
1.00
-
1.11
10.72%
1.09
1.39%
0.96
12.01%
1.05
9.39%
0.65
37.99%
1.26
93.71%
0.52
58.84%
intangibles to total assets
0
-
0
0
0
0
0
0
0.02
Infinity%
interest coverage
-23.48
-
-19.05
18.85%
-7.44
60.95%
-6.80
8.60%
-6.62
2.64%
-10.18
53.72%
-8.44
17.10%
2.66
131.55%
interest debt per share
0.67
-
1.89
181.52%
2.71
43.34%
1.56
42.28%
0.45
71.12%
2.41
433.76%
0.01
99.43%
inventory turnover
0.70
-
0.79
12.79%
0.87
10.63%
0.75
13.13%
0.61
18.80%
1.37
123.30%
1.98
44.65%
invested capital
-0.05
-
-6.98
13,508.37%
0.62
108.95%
0.33
46.61%
0.13
61.99%
0.36
184.33%
3.33
823.63%
market cap
323.73M
-
323.73M
0%
430.34M
32.93%
264.07M
38.64%
491.59M
86.16%
529.14M
7.64%
1.82B
244.76%
2.57T
140,594.35%
net current asset value
-171.69M
-
-12.19M
92.90%
49.35M
504.91%
98.63M
99.86%
51.67M
47.62%
162.52M
214.56%
-58.19M
135.80%
net debt to ebitda
0.17
-
-0.68
499.93%
-0.49
28.51%
-0.41
16.47%
0.42
203.38%
4.12
878.03%
-2.16
152.45%
net income per share
-1.66
-
-1.44
13.47%
-1.23
14.18%
-2.36
91.33%
-1.16
50.72%
-1.60
37.57%
-1.23
23.44%
-0.00
99.94%
operating cash flow per share
-1.67
-
-1.60
4.19%
-1.35
15.37%
-2.27
68.35%
-1.23
46.10%
-1.05
14.69%
-1.55
48.32%
-0.00
99.97%
payables turnover
1.58
-
1.54
2.24%
1.34
12.89%
7.47
455.45%
1.37
81.67%
8.44
516.42%
6.88
18.42%
receivables turnover
8.31
-
3.79
54.43%
3.60
4.95%
3.74
3.79%
5.10
36.53%
3.38
33.63%
3.80
12.28%
research and ddevelopement to revenue
2.52
-
1.95
22.72%
1.05
46.10%
0.84
19.76%
0.73
12.75%
0.74
0.35%
0.29
61.08%
0.15
47.99%
return on tangible assets
-0.56
-
-0.56
0.13%
-0.32
43.46%
-0.19
40.64%
-0.33
73.34%
-0.13
60.12%
-0.04
72.32%
revenue per share
0.43
-
0.53
23.77%
0.68
27.42%
1.66
145.69%
1.04
37.54%
1.10
5.58%
3.16
188.56%
0.01
99.77%
roe
0.12
-
4.92
3,889.42%
-0.61
112.47%
-0.28
54.92%
-0.65
135.49%
-0.19
70.33%
-0.18
5.66%
roic
0.13
-
-0.70
649.91%
-0.33
52.51%
-0.19
42.88%
-0.46
143.33%
-0.12
74.26%
-0.05
57.70%
sales general and administrative to revenue
0.99
-
0.95
4.41%
0.94
-
1.27
34.09%
0.55
56.28%
shareholders equity per share
-11.65
-
-0.25
97.85%
3.85
1,634.59%
4.21
9.32%
2.46
41.58%
6.34
158.02%
0.00
99.93%
stock based compensation to revenue
0.01
-
0.01
25.68%
0.01
21.45%
0.04
227.05%
0.09
160.23%
0.23
141.40%
0.11
51.41%
0.08
25.83%
tangible asset value
-168.72M
-
-4.83M
97.14%
54.65M
1,232.62%
103.89M
90.11%
67.85M
34.69%
187.38M
176.14%
122.86M
34.43%
tangible book value per share
-11.65
-
-0.25
97.85%
3.85
1,634.59%
4.21
9.32%
2.46
41.58%
6.34
158.02%
0.00
99.94%
working capital
23.14M
-
22.24M
3.87%
83.89M
277.17%
134.89M
60.80%
95.47M
29.22%
228.63M
139.49%
455.72M
99.32%

All numbers in (except ratios and percentages)